EDIT — Editas Medicine Cashflow Statement
0.000.00%
Last trade - 00:00- $261.32m
- $173.28m
- $40.52m
Annual cashflow statement for Editas Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -193 | -220 | -153 | -237 | -160 |
| Depreciation | |||||
| Non-Cash Items | 45.1 | 28.6 | 16.6 | 17.6 | 20.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -21.4 | 8.18 | -1.59 | 3.45 | -31.2 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -164 | -177 | -132 | -210 | -165 |
| Capital Expenditures | -7.98 | -4.12 | -4.72 | -8.83 | -0.607 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -46.5 | 118 | 0.988 | 171 | 139 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -54.5 | 114 | -3.73 | 162 | 139 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 282 | 1.28 | 118 | 56 | 40.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 63.8 | -62 | -17.9 | 7.89 | 13.9 |